Cargando…
Cytotoxicity and anti-tumor effects of new ruthenium complexes on triple negative breast cancer cells
Triple-negative breast cancer (TNBC) is a highly aggressive breast cancer subtype. The high rate of metastasis associated to the fact that these cells frequently display multidrug resistance, make the treatment of metastatic disease difficult. Development of antitumor metal-based drugs was started w...
Autores principales: | Popolin, Cecília P., Reis, João P. B., Becceneri, Amanda B., Graminha, Angélica E., Almeida, Márcio A. P., Corrêa, Rodrigo S., Colina-Vegas, Legna A., Ellena, Javier, Batista, Alzir A., Cominetti, Márcia R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5595280/ https://www.ncbi.nlm.nih.gov/pubmed/28898246 http://dx.doi.org/10.1371/journal.pone.0183275 |
Ejemplares similares
-
Synthesis, Characterization, Cytotoxic Activity, and Interactions with CT-DNA and BSA of Cationic Ruthenium(II) Complexes Containing Dppm and Quinoline Carboxylates
por: da Silva, Edinaldo N., et al.
Publicado: (2017) -
A ruthenium-based 5-fluorouracil complex with enhanced cytotoxicity and apoptosis induction action in HCT116 cells
por: Silva, Valdenizia Rodrigues, et al.
Publicado: (2018) -
Development of Copper Complexes with Diimines and Dipicolinate as Anticancer Cytotoxic Agents
por: Alvarez, Natalia, et al.
Publicado: (2023) -
Nanostructured Lipid Systems as a Strategy to Improve the in Vitro Cytotoxicity of Ruthenium(II) Compounds
por: de Freitas, Eduardo Sinesio, et al.
Publicado: (2014) -
Nucleobase Derivatives as Building Blocks to Form
Ru(II)-Based Complexes with High Cytotoxicity
por: Carvalho, Diogo E. L., et al.
Publicado: (2020)